EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages

Zhongyi Fang, Minggao Jiang, Yun Wang, Yiliu Zhou, Mei Zhang iD, Yunfeng Lin iD

Small · 2026-03 · 22 (17)

DOI: 10.1002/smll.202513797 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 06.02.2026. Verfasst von Zhongyi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Macrophages, Nanomedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 292 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Postdoctoral Fellowship Program Grade C of China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the incidence and complexity of autoimmune diseases (AIDs) have been steadily increasing, posing grim challenges to clinical management. These diseases often involve multi‐organ dysfunction and impose a pronounced burden on patients' physical and mental health. Current therapeutic strategies remain suboptimal, frequently limited by poor specificity and severe systemic side effects. With the rapid advancement of nanotechnology, nanodrugs have emerged as a potential approach on account of their enhanced targeting capability, high therapeutic efficacy, and reduced toxicity. In particular, macrophage‐targeted nanodrugs have gained considerable attention, given that macrophages act as a key mediator in the onset and progression of various AIDs. This review systematically summarizes the molecular basis of macrophage involvement in autoimmunity, the design strategies of nanodrugs, and their applications across different AIDs, including rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis (PSO), and systemic lupus erythematosus (SLE). These nanodrugs exert their therapeutic effects primarily by modulating macrophage‐mediated immune responses, specifically through reprogramming macrophage phenotypes to promote anti‐inflammatory and tissue‐reparative functions. By precisely reprogramming macrophage function, these nanotherapeutics offer a novel approach for AID treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesMacrophagesNanomedicineHumansAnimalsNanoparticles

Stichwörter der Autor:innen

autoimmune diseasemacrophage polarizationnanomedicineoxidative stresstargeted delivery

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Mei Zhang, Yunfeng Lin

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Postdoctoral Fellowship Program Grade C of China Postdoctoral Science Foundation
  • West China Hospital of Stomatology Sichuan University
  • Postdoctoral Research Foundation of China
  • Sichuan Province Youth Science and Technology Innovation Team

Zitieren

APA

Fang, Z., Jiang, M., Wang, Y., Zhou, Y., Zhang, M., & Lin, Y. (2026). Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages. Small, 22(17). https://doi.org/10.1002/smll.202513797

Vancouver

Fang Z, Jiang M, Wang Y, Zhou Y, Zhang M, Lin Y. Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages. Small. 2026;22(17). doi:10.1002/smll.202513797

BibTeX
@article{Fang2026,
  author = {Fang, Zhongyi and Jiang, Minggao and Wang, Yun and Zhou, Yiliu and Zhang, Mei and Lin, Yunfeng},
  title = {Nanomedicine Strategies for Autoimmune Diseases: Targeting and Reprogramming Macrophages},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {17},
  doi = {10.1002/smll.202513797}
}
Kostenlos starten →